Evidence map›Paper›PMID 24376809›Full record

ArticlePloS one2013

Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.

Ling Sun, Nalini M Rajamannan, Philippe Sucosky

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ling SunDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana, United States of America ; Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America.
Nalini M RajamannanMolecular Biology and Biochemistry, Mayo Clinic School of Medicine, Rochester, Minnesota, United States of America.
Philippe SucoskyDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana, United States of America ; Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America.
University of Notre Dame · USMayo Clinic · US

Funding

Role of Lrp5/Beta-Catenin in Aortic Valve CalcificationR01HL085591 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RAJAMANNAN, NALINI M · 2007 to 2011
$2.1M
Osteoblastogenesis in Aortic Valve CalcificationK08HL073927 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RAJAMANNAN, NALINI M · 2003 to 2006
$503k
NHLBI NIH HHS K08 HL073927NHLBI NIH HHS R01 HL085591
6 · The paper itself

Abstract

Calcific aortic valve disease (CAVD) is an active process presumably triggered by interplays between cardiovascular risk factors, molecular signaling networks and hemodynamic cues. While earlier studies demonstrated that alterations in fluid shear stress (FSS) on the fibrosa could trigger inflammation, the mechanisms of CAVD pathogenesis secondary to side-specific FSS abnormalities are poorly understood. This knowledge could be critical to the elucidation of key CAVD risk factors such as congenital valve defects, aging and hypertension, which are known to generate FSS disturbances. The objective of this study was to characterize ex vivo the contribution of isolated and combined abnormalities in FSS magnitude and frequency to early valvular pathogenesis. The ventricularis and fibrosa of porcine aortic valve leaflets were exposed simultaneously to different combinations of sub-physiologic/physiologic/supra-physiologic levels of FSS magnitude and frequency for 24, 48 and 72 hours in a double cone-and-plate device. Endothelial activation and paracrine signaling were investigated by measuring cell-adhesion molecule (ICAM-1, VCAM-1) and cytokine (BMP-4, TGF-β1) expressions, respectively. Extracellular matrix (ECM) degradation was characterized by measuring the expression and activity of the proteases MMP-2, MMP-9, cathepsin L and cathepsin S. The effect of the FSS treatment yielding the most significant pathological response was examined over a 72-hour period to characterize the time-dependence of FSS mechano-transduction. While cytokine expression was stimulated under elevated FSS magnitude at normal frequency, ECM degradation was stimulated under both elevated FSS magnitude at normal frequency and physiologic FSS magnitude at abnormal frequency. In contrast, combined FSS magnitude and frequency abnormalities essentially maintained valvular homeostasis. The pathological response under supra-physiologic FSS magnitude peaked at 48 hours but was then maintained until the 72-hour time point. This study confirms the sensitivity of valve leaflets to both FSS magnitude and frequency and suggests the ability of supra-physiologic FSS levels or abnormal FSS frequencies to initiate CAVD mechanisms.

Indexed as

Analysis of VarianceAortic ValveBicuspid Aortic Valve DiseaseBiomechanical PhenomenaBone Morphogenetic Protein 4CalcinosisCathepsin LCathepsinsCell Adhesion Molecule-1Cell Adhesion MoleculesExtracellular MatrixGene Expression RegulationHeart Defects, CongenitalHeart Valve DiseasesHemodynamicsHumansBMP4 protein, humanBone Morphogenetic Protein 4CADM1 protein, humanCathepsin Lcathepsin SCathepsinsCell Adhesion Molecule-1Cell Adhesion MoleculesImmunoglobulinsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Transforming Growth Factor beta1

Identifiers

PMID24376809
PMCPMC3871675
OpenAlexW2071037816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.